The Food and Drug Administration’s panel of reproductive health experts voted 19-5 that the benefits of the ethinyl estradiol and norelgestromin transdermal [Ortho Evra] patch outweigh its risks, specifically a potentially higher risk of dangerous blood clots in the legs and lungs. FDA panelists said the patch can be especially useful for younger women who have difficulty sticking to a daily pill regimen. Despite the safety concerns, the experts stressed that Ortho Evra fills a unique niche among birth-control products.
don’t really know how you can compare the risk vs benefits in this. always bothered me. the benefit is not getting pregnant. the risk is getting a blood clot and dying (and breast cancer). it’s not even on the same level. i think it’s really a personal preference. how can we generalize so much?